Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin and circadian rhythm correction training in cardiac patients
IRCT20260504069257N1Phase 2Recruiting
- Sponsor
- Tehran University of Medical Sciences
- Start
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of melatonin in cardiac disease and myocardial infarction (MI) (4 arms), sponsored by Tehran University of Medical Sciences. Started Jun 2026; status: recruiting.
02
Drugs
melatonin
03
Conditions
cardiac diseasemyocardial infarction (MI)
Beyond the preview
Go deeper on IRCT20260504069257N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20260504069257N1.